IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

FRANCESKA SEVERE-DEJOIE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1265192314
CMS profile
11325995
Location
BREINIGSVILLE, PA

General Payments · PY2022–2025

$5,723.76

  • Reported across 212 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$2,523.82

66 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Nurse Practitioner PA All categories

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,320.69 53
Long term medical supply or device loan $1,180.03 12
Education $23.10 1

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $1,411.98 31
Acerta Pharma LLC $241.74 9
PFIZER INC. $166.61 3
Boehringer Ingelheim Pharmaceuticals, Inc. $142.77 2
Agios Pharmaceuticals, Inc. $124.96 1
Daiichi Sankyo Inc. $99.10 4
ABBVIE INC. $60.03 3
Incyte Corporation $41.13 2
JAZZ PHARMACEUTICALS INC. $37.11 1
Janssen Biotech, Inc. $34.33 2
Coherus Biosciences Inc. $25.64 1
Ipsen Biopharmaceuticals, Inc $25.24 1
Blueprint Medicines Corporation $23.95 1
EMD Serono, Inc. $22.15 1
EISAI INC. $20.83 1
Merck Sharp & Dohme Corporation $17.48 1
Astellas Pharma US Inc $15.00 1
Azurity Pharmaceuticals, Inc. $13.77 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $453.24 22
PY2023 $1,085.06 47
PY2024 $1,661.64 77
PY2025 $2,523.82 66

Payment records · PY2025 (66)

Sorted by paying entity, then date · as published by CMS

Program year 2025 202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $25.14 06/03/2025 Food and Beverage Undisputed 06/30/2026 1204175892 CMS
ABBVIE INC. $16.24 06/25/2025 Food and Beverage Undisputed 06/30/2026 1204175896 CMS
ABBVIE INC. $18.65 07/10/2025 Food and Beverage Undisputed 06/30/2026 1204175900 CMS
Agios Pharmaceuticals, Inc. $124.96 12/05/2025 Food and Beverage Undisputed 06/30/2026 1253250628 CMS
Astellas Pharma US Inc $15.00 10/01/2025 Food and Beverage Undisputed 06/30/2026 1238673149 CMS
AstraZeneca Pharmaceuticals LP $24.00 01/09/2025 Food and Beverage Undisputed 06/30/2026 1242522681 CMS
AstraZeneca Pharmaceuticals LP $66.61 01/10/2025 Food and Beverage Undisputed 06/30/2026 1242519286 CMS
AstraZeneca Pharmaceuticals LP $13.52 02/05/2025 Food and Beverage Undisputed 06/30/2026 1242522433 CMS
AstraZeneca Pharmaceuticals LP $26.15 02/26/2025 Food and Beverage Undisputed 06/30/2026 1242516430 CMS
AstraZeneca Pharmaceuticals LP $23.10 05/28/2025 Education Undisputed 06/30/2026 1242513892 CMS
AstraZeneca Pharmaceuticals LP $22.78 05/28/2025 Food and Beverage Undisputed 06/30/2026 1242522565 CMS
AstraZeneca Pharmaceuticals LP $14.61 06/28/2025 Food and Beverage Undisputed 06/30/2026 1242522769 CMS
AstraZeneca Pharmaceuticals LP $21.70 08/29/2025 Food and Beverage Undisputed 06/30/2026 1242515498 CMS
AstraZeneca Pharmaceuticals LP $29.27 09/12/2025 Food and Beverage Undisputed 06/30/2026 1242522693 CMS
Azurity Pharmaceuticals, Inc. $13.77 04/30/2025 Food and Beverage Undisputed 06/30/2026 1242689296 CMS
Blueprint Medicines Corporation $23.95 05/09/2025 Food and Beverage Undisputed 06/30/2026 1235820620 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.13 07/25/2025 Food and Beverage Undisputed 06/30/2026 1222784622 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $120.64 10/15/2025 Food and Beverage Undisputed 06/30/2026 1222784624 CMS
Coherus Oncology, Inc. $25.64 03/14/2025 Food and Beverage Undisputed 06/30/2026 1235240123 CMS
Daiichi Sankyo Inc. $23.76 04/10/2025 Food and Beverage Undisputed 06/30/2026 1197060595 CMS
Daiichi Sankyo Inc. $23.50 04/23/2025 Food and Beverage Undisputed 06/30/2026 1197039629 CMS
Daiichi Sankyo Inc. $25.05 06/27/2025 Food and Beverage Undisputed 06/30/2026 1197087449 CMS
Daiichi Sankyo Inc. $26.79 10/08/2025 Food and Beverage Undisputed 06/30/2026 1197010159 CMS
Eisai Inc. $20.83 02/13/2025 Food and Beverage Undisputed 06/30/2026 1244532017 CMS
EMD Serono, Inc. $22.15 05/22/2025 Food and Beverage Undisputed 06/30/2026 1236906053 CMS
Incyte Corporation $21.24 07/12/2025 Food and Beverage Undisputed 06/30/2026 1226008435 CMS
Incyte Corporation $19.89 10/18/2025 Food and Beverage Undisputed 06/30/2026 1226181841 CMS
Ipsen Biopharmaceuticals, Inc $25.24 05/15/2025 Food and Beverage Undisputed 06/30/2026 1208858894 CMS
Janssen Biotech, Inc. $18.62 03/22/2025 Food and Beverage Undisputed 06/30/2026 1174518079 CMS
Janssen Biotech, Inc. $15.71 11/25/2025 Food and Beverage Undisputed 06/30/2026 1174518089 CMS
JAZZ PHARMACEUTICALS INC. $37.11 04/26/2025 Food and Beverage Undisputed 06/30/2026 1234905997 CMS
Merck Sharp & Dohme LLC $17.48 08/20/2025 Food and Beverage Undisputed 06/30/2026 1238021924 CMS
Novartis Pharmaceuticals Corporation $99.70 01/23/2025 Long term medical supply or device loan Undisputed 06/30/2026 1200396062 CMS
Novartis Pharmaceuticals Corporation $5.71 02/05/2025 Food and Beverage Undisputed 06/30/2026 1200396068 CMS
Novartis Pharmaceuticals Corporation $28.93 02/14/2025 Food and Beverage Undisputed 06/30/2026 1200396072 CMS
Novartis Pharmaceuticals Corporation $12.10 02/19/2025 Food and Beverage Undisputed 06/30/2026 1200396074 CMS
Novartis Pharmaceuticals Corporation $0.52 02/19/2025 Food and Beverage Undisputed 06/30/2026 1200396076 CMS
Novartis Pharmaceuticals Corporation $99.70 02/21/2025 Long term medical supply or device loan Undisputed 06/30/2026 1200396064 CMS
Novartis Pharmaceuticals Corporation $14.76 03/11/2025 Food and Beverage Undisputed 06/30/2026 1200396070 CMS
Novartis Pharmaceuticals Corporation $22.59 03/21/2025 Food and Beverage Undisputed 06/30/2026 1200396080 CMS
Novartis Pharmaceuticals Corporation $99.70 03/26/2025 Long term medical supply or device loan Undisputed 06/30/2026 1200396066 CMS
Novartis Pharmaceuticals Corporation $16.05 03/31/2025 Food and Beverage Undisputed 06/30/2026 1200396086 CMS
Novartis Pharmaceuticals Corporation $99.70 04/24/2025 Long term medical supply or device loan Undisputed 06/30/2026 1200396034 CMS
Novartis Pharmaceuticals Corporation $99.70 05/15/2025 Long term medical supply or device loan Undisputed 06/30/2026 1200396032 CMS
Novartis Pharmaceuticals Corporation $2.65 05/16/2025 Food and Beverage Undisputed 06/30/2026 1200396082 CMS
Novartis Pharmaceuticals Corporation $19.57 05/16/2025 Food and Beverage Undisputed 06/30/2026 1200396088 CMS
Novartis Pharmaceuticals Corporation $0.95 05/16/2025 Food and Beverage Undisputed 06/30/2026 1200396090 CMS
Novartis Pharmaceuticals Corporation $5.83 05/22/2025 Food and Beverage Undisputed 06/30/2026 1200396084 CMS
Novartis Pharmaceuticals Corporation $99.70 06/12/2025 Long term medical supply or device loan Undisputed 06/30/2026 1200396036 CMS
Novartis Pharmaceuticals Corporation $14.62 07/07/2025 Food and Beverage Undisputed 06/30/2026 1200396092 CMS
Novartis Pharmaceuticals Corporation $99.70 07/25/2025 Long term medical supply or device loan Undisputed 06/30/2026 1200396038 CMS
Novartis Pharmaceuticals Corporation $3.12 07/30/2025 Food and Beverage Undisputed 06/30/2026 1200396094 CMS
Novartis Pharmaceuticals Corporation $11.72 08/05/2025 Food and Beverage Undisputed 06/30/2026 1200396098 CMS
Novartis Pharmaceuticals Corporation $99.70 08/21/2025 Long term medical supply or device loan Undisputed 06/30/2026 1200396040 CMS
Novartis Pharmaceuticals Corporation $26.98 08/22/2025 Food and Beverage Undisputed 06/30/2026 1200396096 CMS
Novartis Pharmaceuticals Corporation $15.20 09/15/2025 Food and Beverage Undisputed 06/30/2026 1200396108 CMS
Novartis Pharmaceuticals Corporation $99.70 09/19/2025 Long term medical supply or device loan Undisputed 06/30/2026 1200396060 CMS
Novartis Pharmaceuticals Corporation $6.69 09/20/2025 Food and Beverage Undisputed 06/30/2026 1200396106 CMS
Novartis Pharmaceuticals Corporation $7.56 10/15/2025 Food and Beverage Undisputed 06/30/2026 1200396112 CMS
Novartis Pharmaceuticals Corporation $99.70 10/23/2025 Long term medical supply or device loan Undisputed 06/30/2026 1200396042 CMS
Novartis Pharmaceuticals Corporation $99.70 11/26/2025 Long term medical supply or device loan Undisputed 06/30/2026 1200396044 CMS
Novartis Pharmaceuticals Corporation $16.40 12/03/2025 Food and Beverage Undisputed 06/30/2026 1200422040 CMS
Novartis Pharmaceuticals Corporation $83.33 12/30/2025 Long term medical supply or device loan Undisputed 06/30/2026 1200396058 CMS
PFIZER INC. $22.02 05/20/2025 Food and Beverage Undisputed 06/30/2026 1230072834 CMS
PFIZER INC. $120.78 07/24/2025 Food and Beverage Undisputed 06/30/2026 1230217110 CMS
PFIZER INC. $23.81 09/23/2025 Food and Beverage Undisputed 06/30/2026 1230402084 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.